サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390726

乾癬性関節炎治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Psoriatic Arthritis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
乾癬性関節炎治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

乾癬性関節炎治療の世界市場規模は2022年に87億米ドルに達しました。今後、IMARC Groupは、2022年から2028年にかけて10.57%の成長率（CAGR）を示し、2028年までに159億米ドルに達すると予測しています。

乾癬性関節炎は、免疫系が関節を攻撃して炎症を引き起こす自己免疫疾患です。治療の選択肢は、腫れや炎症を抑える内服薬から、特定の免疫系を標的とする生物学的療法まで様々です。痛み、腫れ、こわばりの程度に応じて治療が行われます。現在、主要企業は疾患の進行を防ぎ、痛みを軽減し、関節を保護し、可動域を維持する新しい治療法を導入しています。これらの方法は、筋肉や関節を強化し、全体的な安定性を高める理学療法と組み合わせることができます。

乾癬性関節炎治療市場の動向：

乾癬疾患は、乾癬性関節炎の主要な危険因子の1つです。その結果、感染症、ストレス、肥満、皮膚損傷、アルコール乱用、ビタミン欠乏による乾癬疾患の有病率の増加は、市場にプラスの影響を与える主な要因の1つとなっています。さらに、乾癬性関節炎は30歳から50歳の間で最も一般的に発症するため、世界の成人人口の増加が市場の成長に寄与しています。これとは別に、乾癬性関節炎を患う小児は、眼球の中層組織を侵すぶどう膜炎を発症する可能性が高いです。このことは、子供の健康に対する両親の関心の高まりと相まって、世界中で乾癬性関節炎治療薬の需要を喚起しています。さらに、早期診断と早期治療による深刻なダメージの防止などの利点に対する意識の高まりが、市場の成長を後押ししています。その他、個人の可処分所得の増加、ヘルスケア施設の改善、個人の健康意識の高まりなどが、重篤な症状と闘うための新規の乾癬性関節炎治療薬に対する需要を促進すると予想されます。

本レポートで扱う主な質問

  • 乾癬性関節炎治療薬の世界市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が世界の乾癬性関節炎治療市場に与えた影響は？
  • 主要な地域市場は？
  • 薬剤タイプ別の市場内訳は？
  • タイプ別の市場内訳は？
  • 投与経路別の市場内訳は？
  • 流通チャネル別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の乾癬性関節炎治療薬市場の構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 乾癬性関節炎治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤タイプ別

  • NSAIDs（非ステロイド性抗炎症薬）
    • 市場動向
    • 市場予測
  • DMARDs（疾患修飾性抗リウマチ薬）
    • 市場動向
    • 市場予測
  • 生物製剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：タイプ別

  • 処方箋
    • 市場動向
    • 市場予測
  • 一般用医薬品
    • 市場動向
    • 市場予測

第8章 市場内訳：投与経路別

  • 注射
    • 市場動向
    • 市場予測
  • 経口
    • 市場動向
    • 市場予測
  • 外用
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB S.A.
図表

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2022
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2022
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players
目次
Product Code: SR112023A4541

Abstract

The global psoriatic arthritis treatment market size reached US$ 8.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.57% during 2022-2028.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global psoriatic arthritis treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type, type, route of administration and distribution channel.

Breakup by Drug Type:

NSAIDs (Nonsteroidal Anti-Inflammatory drugs)

DMARDs (Disease-Modifying Anti-Rheumatic Drugs)

Biologics

Others

Breakup by Type:

Prescription

OTC

Breakup by Route of Administration:

Injectable

Oral

Topical

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis